Your browser doesn't support javascript.
loading
Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factors.
Oh, Eun Hye; Oh, Kyunghwan; Han, Minkyu; Seo, Hyungil; Chang, Kiju; Lee, Sun-Ho; Kim, Gwang-Un; Song, Eun Mi; Seo, Myeongsook; Lee, Ho-Su; Hwang, Sung Wook; Park, Sang Hyoung; Yang, Dong-Hoon; Kim, Kyung-Jo; Byeon, Jeong-Sik; Myung, Seung-Jae; Yang, Suk-Kyun; Ye, Byong Duk.
Afiliação
  • Oh EH; Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Oh K; Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Han M; Department of Clinical Epidemiology and Biostatistics, University of Ulsan College of Medicine, Seoul, Korea.
  • Seo H; Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Chang K; Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Lee SH; Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Kim GU; Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Song EM; Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Seo M; Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Lee HS; Health Screening and Promotion Center, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Hwang SW; Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Park SH; Inflammatory Bowel Disease Center, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Yang DH; Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Kim KJ; Inflammatory Bowel Disease Center, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Byeon JS; Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Myung SJ; Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Yang SK; Inflammatory Bowel Disease Center, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Ye BD; Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
PLoS One ; 12(5): e0177479, 2017.
Article em En | MEDLINE | ID: mdl-28542298

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Crohn / Imunomodulação / Fatores Imunológicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male País como assunto: Asia Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Crohn / Imunomodulação / Fatores Imunológicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male País como assunto: Asia Idioma: En Ano de publicação: 2017 Tipo de documento: Article